Mehdi Hamadani, M.D – FDA Inspection, May 23, 2024

Record Details

This FDA Inspection record concerns Mehdi Hamadani, M.D, with an inspection on May 23, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Mehdi Hamadani, M.D
Inspection Date: May 23, 2024
Product Type: Drugs
Office: Center for Drug Evaluation and Research
Person: Denise L. Burosh (FDA Associated Person)

View Company Profile

ID · 59d4277e-713d-431f-b119-7b311960c05f

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number: 1239290
FDA center: Human Drugs
Project area: Bioresearch Monitoring

FDA Citations

21 CFR 312.60FD-1572, protocol compliance
21 CFR 312.66Initial and continuing review

Full citation text and observation details available on the Dashboard.

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Mehdi Hamadani, M.D

FDA Inspection

Mehdi Hamadani, M.DMay 23, 2024